All comparisons
BMY vs MRK
Bristol-Myers Squibb Company vs Merck & Co., Inc.
Overview
BMYBristol-Myers Squibb Company
Score APrice
$64.41
Fair Value
$70.23
Upside
+9.0%
Convex Score
10/10
MRKMerck & Co., Inc.
Score APrice
$147.60
Fair Value
$176.01
Upside
+19.2%
Convex Score
10/10
Valuation
BMY
Bear$57.97
Base$94.72
Bull$147.05
Fair Value$70.23
MRK
Bear$132.84
Base$176.56
Bull$212.51
Fair Value$176.01
Quality
BMY
Grade
B
Score
75/100
Classification
Value
Rating
Score A
MRK
Grade
B
Score
83/100
Classification
Blue Chip
Rating
Score A
Company Info
| BMY | MRK | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Value | Blue Chip |
Verdict
MRK has better risk/reward
MRK: Higher upside potentialMRK: Better quality grade